Kanaph Therapeutics

Developer of tumor micro-environment targeting drugs designed to cure solid tumors. The company aims to enhance patient response rates for immuno-oncology drugs by overcoming immune suppression in the...

Healthcare

Seoul, South Korea

Founded 2019

16 employees

Website

Valuation

Share Price

N/A

Total Raised

$46.6M

Last Round

N/A

Investors

+12 other investors

View all 12 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock Kanaph Therapeutics's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required